EMEA-002974-PIP01-21

Key facts

Active substance
Benzylamine derivative of benzofuran (BCX9930)
Therapeutic area
Haematology-Hemostaseology
Decision number
P/0125/2022
PIP number
EMEA-002974-PIP01-21
Pharmaceutical form(s)
  • Age-appropriate oral solid dosage form
  • Tablet
Condition(s) / indication(s)
Treatment of paroxysmal nocturnal haemoglobinuria
Route(s) of administration
Oral use
Contact for public enquiries
BioCryst Ireland Limited

 +1 9842450602

pip.enquiries@biocryst.com

 

 

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating